These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3230974)

  • 1. [Increase in serum mucin-like carcinoma-associated antigen (MCA) in patients with chronic liver diseases].
    Soriano A; Pombo L; Sagredo E; Ruibal A
    Med Clin (Barc); 1988 Nov; 91(17):675. PubMed ID: 3230974
    [No Abstract]   [Full Text] [Related]  

  • 2. MCA performance in preoperative breast cancer patients.
    Donadeo A; Micelli G; Quaranta M; Atlante A; Schittulli F
    Anticancer Res; 1995; 15(2):527-9. PubMed ID: 7763034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pre- and post-therapeutic serum concentrations of mucin-like carcinoma-associated antigen in patients with breast cancer].
    Fuith LC; Artner-Dworzak E; Schröcksnadel H; Müller-Holzner E; Daxenbichler G; Heim K
    Gynakol Rundsch; 1989; 29 Suppl 2():397-9. PubMed ID: 2613061
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of mucin-like carcinoma-associated antigen in the cyst fluid differentiates mucinous from nonmucinous pancreatic cysts.
    Sperti C; Pasquali C; Pedrazzoli S; Guolo P; Liessi G
    Am J Gastroenterol; 1997 Apr; 92(4):672-5. PubMed ID: 9128321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum concentrations of the MCA tumor marker during pregnancy].
    Pütz I; Lang G; Winkler M; Rath W
    Zentralbl Gynakol; 1996; 118(7):409-11. PubMed ID: 8766103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
    Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E
    Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA 15-3, mucin-like carcinoma-associated antigen and tissue polypeptide-specific antigen: correlation to disease state and prognosis in breast cancer patients.
    Cohen AD; Gopas J; Karplus G; Cohen Y
    Isr J Med Sci; 1995; 31(2-3):155-9. PubMed ID: 7744585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High BCM serum levels in patients with non breast tumors: first results.
    Allende T; Vizoso F; Roiz C; Fueyo A; Lennartz L; Ruibal A
    Bull Cancer; 1990; 77(10):1031-2. PubMed ID: 2249013
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tumor markers in the diagnosis and prognosis of breast cancer].
    Seliuzhitskiĭ IV; Skvortsov SV; Lytsar BN; Khomenko LP
    Klin Med (Mosk); 1993; 71(2):25-7. PubMed ID: 8046917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The antigen associated with squamous cell carcinoma in patients with benign hepatopathies].
    Collazos J
    Med Clin (Barc); 1997 Feb; 108(4):157. PubMed ID: 9162788
    [No Abstract]   [Full Text] [Related]  

  • 11. [The cytosolic concentrations of CAM26 and CAM29 in breast tumors classified according to the clinical stage].
    Fernández M; Suárez B; González C; Allende MT
    Rev Clin Esp; 1992 May; 190(9):480-1. PubMed ID: 1626101
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer.
    Ogawa Y; Ishikawa T; Ikeda K; Nakata B; Sawada T; Ogisawa K; Kato Y; Hirakawa K
    Clin Cancer Res; 2000 Oct; 6(10):4069-72. PubMed ID: 11051258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mucoid carcinoma antigen--a new tumor marker].
    Bieglmayer C; Szepesi T; Neunteufel W
    Gynakol Rundsch; 1988; 28 Suppl 2():203-5. PubMed ID: 3234919
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum CEA, CA 15-3, and MCA in breast cancer patients: a clinical evaluation.
    Repetto L; Onetto M; Gardin G; Costanzi B; Giudici S; Vitiello E; Merlini L; Naso C; Zannini C; Paganuzzi M
    Cancer Detect Prev; 1993; 17(3):411-5. PubMed ID: 8402728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum marker combinations in human breast cancer (review).
    Lamerz R; Stieber P; Fateh-Moghadam A
    In Vivo; 1993; 7(6B):607-13. PubMed ID: 8193281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum TAG-72 in women with breast cancer: an example of serum/tissue discrepancy of a tumor marker].
    Ruibal A; Sagredo E; Soriano A; Roiz MC
    Med Clin (Barc); 1989 Jan; 92(1):39. PubMed ID: 2716383
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum CYFRA 21-1 is one of the most reliable tumor markers for breast carcinoma.
    Rodríguez CA; Cruz JJ; Martín T; Gómez A; Olaverri A; Hernández M
    Cancer; 2002 Aug; 95(3):670-1; author reply 671. PubMed ID: 12209762
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tumor markers in breast cancer].
    Kurebayashi J
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):2077-81. PubMed ID: 15570944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mucin markers in metastatic breast cancer].
    Bieglmayer C; Breitenecker G; Szepesi T
    Gynakol Rundsch; 1990; 30 Suppl 1():142-4. PubMed ID: 2079249
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum tumor markers in chronic liver disease.
    Kadayifci A; Simsek H; Savas MC; Toppare M
    Neoplasma; 1996; 43(1):17-21. PubMed ID: 8843954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.